Exploring the clinical utility of measuring reversibility in mid expiratory flow and its relationship with FEV1 reversibility in patients with asthma.

I. Laska (Prahran, VIC, Australia)

Source: International Congress 2017 – Biomarker-based asthma control
Session: Biomarker-based asthma control
Session type: Thematic Poster
Number: 3993
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Laska (Prahran, VIC, Australia). Exploring the clinical utility of measuring reversibility in mid expiratory flow and its relationship with FEV1 reversibility in patients with asthma.. 3993

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Utility of peak expiratory flow for bronchodilator reversibility assessment
Source: Annual Congress 2007 - Lung function II
Year: 2007


Comparison between peak expiratory flow rate (PEFR) and FEV1 in the monitoring of children suspected to asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 506s
Year: 2002

Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma
Source: Eur Respir J 2004; 23: 730-734
Year: 2004



Can the prediction point for FEV1 / FVC be determined in patients with insufficient expiratory maneuver to determine airflow obstruction?
Source: Virtual Congress 2020 – Advances in lung function testing
Year: 2020


The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013

The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002

The effect of shift work on serial peak expiratory flow measurements used for diagnosing occupational asthma
Source: Annual Congress 2010 - Occupational asthma
Year: 2010

Peak expiratory flow value and relationships between functional parameters in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 808s
Year: 2006

The significance of regular peak expiratory flow monitoring in severe childhood asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 165s
Year: 2005

The importance of expiratory flow rate measuring in the differential diagnosis of chronic bronchial obstruction in children
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009

Variation of electronically measured peak expiratory flow and asthma severity in children
Source: Eur Respir J 2004; 24: Suppl. 48, 687s
Year: 2004

Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma
Source: Eur Respir J 2009; 34: 574
Year: 2009



Is residual volume reversibility a better marker than FEV1 reversibility in diagnosing reversible airway disease  in asthma?
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017



Forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF): is there a correlation in chronic obstructive pulmonary disease (COPD) patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001

Clinical characteristics of COPD patients with tidal expiratory flow limitation
Source: International Congress 2017 – Lung function testing
Year: 2017

Auscultatory forced expiratory time as a predictor of FEV1 and as a clinical test of airway obstruction
Source: Eur Respir J 2004; 24: Suppl. 48, 225s
Year: 2004

Characteristics of asthmatic patients with a good vs poor correlation between clinical criteria of asthma control and expiratory flows
Source: Eur Respir J 2003; 22: Suppl. 45, 536s
Year: 2003

Peak expiratory flow use for screening airflow obstruction and monitoring the bronchodilator effect in COPD patients in primary care settings
Source: Eur Respir J 2006; 28: Suppl. 50, 738s
Year: 2006

FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007



Post-bronchodilator changes in volumes and airway caliber according to Peak flow and FEV1 reversibility
Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children
Year: 2019